bio2018-mybio-icons-attendees
Position
President and CEO
Company
Adocia
Location
Venissieux FRANCE
Bio
Gérard Soula has a PhD in Organic chemistry and has an MBA from IAE (Aix Marseille). He founded Flamel Technologies (in 1990), a biotech company specialized in Drug Delivery and listed on Nasdaq. He was the CEO and Director of Research until June 2005. When he left, Flamel had 250 employees, $100M cash in bank and a market capitalization of $500M. Flamel Technologies’ success is based on the performances of its platforms, Micropump and Medusa. Furthermore, Gérard Soula has a strong track record in negotiating license agreements in innovating technologies with big pharma groups (Novo Nordisk, Bristol Myers Squibb, GlaxoSmithKline etc). He is the co-author of more than 120 patents.
Agenda
bio2018-mybio-sessionicon-companypres

2:45 PM–3:00 PM Jun 4, 2018 (US - Eastern)

Theater 4, Level 0

Interests
None yet.